Premium
Sympathetic overactivity in dialysis patients—Underappreciated and clinically consequential
Author(s) -
Hoye Neil A.,
Wilson Luke C.,
Jardine David L.,
Walker Robert J.
Publication year - 2018
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/sdi.12756
Subject(s) - medicine , intensive care medicine , dialysis
Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence‐based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to afferent nerve signaling from the diseased native kidneys, has been established to be prognostic in the dialysis population for over 15 years. Despite this, tangible therapeutic interventions have, to date, been unsuccessful and the outlook for patients remains poor. This narrative review summarizes established experimental and clinical data, highlighting recent developments, and proposes why interventions to ameliorate sympathetic hyperactivity may well be beneficial for this high‐risk population.